To assess the incidence of radiation-induced skin lesions following PCI.
We conducted a prospective, observational, single-centre study on the incidence of radiation-induced skin lesions at 3–5 days (acute) and at 6 months (subacute) after PCI with a dose–area product (DAP) ≥ 200 Gy/cm2, between 1 January and 31 December 2013. Patients consenting to participate were given information on potential skin lesions and were interviewed at 5–7 days and at 6 months after the PCI.
In total, 1168 PCIs were performed; the radiation dose was available for 937 patients. Of these, 102 underwent PCI with DAP ≥ 200 Gy/cm2. High body mass index (BMI; OR 6.2, 95% CI 2.8–13.9) and elective (vs emergency) procedures (OR 2.0, 95% CI 1.1–3.4) were independently associated with DAP ≥ 200 Gy/cm2. Three patients (3%, 95% CI 0.6–8.4) were diagnosed with acute lesions (DAP of 485 Gy/cm2, 205 Gy/cm2, and 201 Gy/cm2), two of whom also presented with subacute lesions following PCI with DAP of 485 Gy/cm2 (Fig. 1) and 205 Gy/cm2. One patient presented with a subacute lesion (DAP 280 Gy/cm2) only. Four patients presented with a skin lesion, which represents 4% (95% CI 1.1–9.7) of patients with DAP ≥ 200 Gy/cm2 and 0.4% (95% CI 0.1–1.1) of all the patients who underwent PCI, irrespective of DAP dose.
The incidence of radiation-induced acute and subacute skin lesions developing after PCI in this single-centre study was 4% in patients with DAP ≥ 200 Gy/cm2, with a total incidence of 0.4%. These data may suggest the need for systematic assessment of skin lesions after high-dose radiation PCI.